It took a petition filed for Nitto Denko Corporation to expose backlogs and pendency at the Indian Patent Office – and force a revisit of expedited applications. Nitto
Archana Shanker discusses the changing patent litigation landscape in India, and why the telecommunications industry has started to favour litigation as a remedial measure. What with so many influential patent cases
In a breakthrough decision with significant implications for patent prosecution in India, an Indian court has read “wilfulness” into Section 8 of India’s Patents Act. A Delhi High
India, in order to climb the intellectual property and innovation indexes, has to strike the right balance between providing public health to all and, at the same time,
While PCT Application is a beneficial tool for patent applicants planning to obtain protection outside India, they ought to be careful in cases of filing first in India
Archana Shanker and Shraddha Chauhan look at ways in which India can and should be using competition law to underpin patent rights in a monopoly-hungry environment. Patent litigation
Setting precedent for disputes involving a challenge against validity of a patent, the Supreme Court concluded that a party opposing grant of patent cannot pursue revocation petitions before
Arguments over the term of the patents granted are at the heart of the Copaxone conflict, says Archana Shanker. Copaxone (glatiramer acetate) is a blockbuster drug for the
April 2014 marks the first anniversary of the judgment of the Indian Supreme Court in the Novartis case, wherein the decision of the Indian Patent Office refusing grant
Due in part to its often-ambiguous requirements, Section 8 of India’s Patents Act has become a nightmare for patent owners, explains Pravin Anand. The 2009 Chemtura decision of
